This is not a pure top-line story. The upside comes from improving earnings quality: more long-duration nuclear and gas contracts,
Cogentrix scale, selective
brownfield development, and reliability-oriented products should make cash flows steadier and more strategic to AI-era
load growth. Versus peers, Vistra still deserves a
discount to the cleanest nuclear scarcity names, but a better mix and continued buybacks can support a moderate
rerating and equity value more than doubling.